RxNorm 1536836
ranitidine (as ranitidine hydrochloride) 150 mg Effervescent Oral Tablet
RxNorm Semantic Concepts
RxNorm semantic concepts for the RxCUI 1536836 unique identifier include: ranitidine (as ranitidine hydrochloride) 150 mg Effervescent Oral Tablet (6336634), ranitidine 150 MG Effervescent Oral Tablet (12346904), Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release effervescent oral tablet (clinical drug) (10316783) and Ranitidine (as ranitidine hydrochloride) 150 mg effervescent oral tablet (10320019).
RxNorm Atom ID: 6336634 - Synonym
ranitidine (as ranitidine hydrochloride) 150 mg Effervescent Oral Tablet
- RXCUI:
- 1536836 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 6336634 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- NO - This drug IS NOT part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.
- Concept Description:
- ranitidine (as ranitidine hydrochloride) 150 mg Effervescent Oral Tablet - Description of concept identifier
- Term Type (TTY):
- SY - Term type in source with name and description
- Term Type Name:
- Synonym - Name of term type in source
- Term Type Description:
- Synonym of another TTY, given for clarity. - Description of term type in source
- Code:
- 1536836 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- RXNORM - Concept source abbreviation
- Source Name:
- RxNorm Vocabulary - The official name for a source
- Source Version:
- 20AA_240401F - The source version
- Source Date:
- March 04, 2024 - RxNorm data last updated
- Source License Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information - Source Content Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information - Source Short Name:
- RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server
RxNorm Atom ID: 12346904 - Semantic Clinical Drug
ranitidine 150 MG Effervescent Oral Tablet
- RXCUI:
- 1536836 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 12346904 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- NO - This drug IS NOT part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.
- Concept Description:
- ranitidine 150 MG Effervescent Oral Tablet - Description of concept identifier
- Term Type (TTY):
- SCD - Term type in source with name and description
- Term Type Name:
- Semantic Clinical Drug - Name of term type in source
- Term Type Description:
- Ingredient + Strength + Dose Form - Description of term type in source
- Code:
- 1536836 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- RXNORM - Concept source abbreviation
- Source Name:
- RxNorm Vocabulary - The official name for a source
- Source Version:
- 20AA_240401F - The source version
- Source Date:
- March 04, 2024 - RxNorm data last updated
- Source License Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information - Source Content Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information - Source Short Name:
- RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server
RxNorm Atom 12346904 Attributes
Property | Value | Explanation |
---|---|---|
RXN AI | {328494} 203136 | RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value |
RXN AM | {328494} 9143 | RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value |
RXN BOSS FROM | {328494} AM | Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value |
RxNorm Atom ID: 10316783 - Full form of descriptor
Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release effervescent oral tablet (clinical drug)
- RXCUI:
- 1536836 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 10316783 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- NO - This drug IS NOT part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.
- Concept Description:
- Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release effervescent oral tablet (clinical drug) - Description of concept identifier
- Term Type (TTY):
- FN - Term type in source with name and description
- Term Type Name:
- Full form of descriptor - Name of term type in source
- Term Type Description:
- - Description of term type in source
- Code:
- 317238000 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- SNOMEDCT_US - Concept source abbreviation
- Source Name:
- US Edition of SNOMED CT - The official name for a source
- Source Version:
- 2024_01_01 - The source version
- Source Date:
- March 04, 2024 - RxNorm data last updated
- Source License Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source license contact information - Source Content Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source content contact information - Source Short Name:
- US Edition of SNOMED CT - The short name of a source as used by the NLM Knowledge Source Server
RxNorm Atom ID: 10320019 - Designated preferred name
Ranitidine (as ranitidine hydrochloride) 150 mg effervescent oral tablet
- RXCUI:
- 1536836 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 10320019 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- NO - This drug IS NOT part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.
- Concept Description:
- Ranitidine (as ranitidine hydrochloride) 150 mg effervescent oral tablet - Description of concept identifier
- Term Type (TTY):
- PT - Term type in source with name and description
- Term Type Name:
- Designated preferred name - Name of term type in source
- Term Type Description:
- - Description of term type in source
- Code:
- 317238000 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- SNOMEDCT_US - Concept source abbreviation
- Source Name:
- US Edition of SNOMED CT - The official name for a source
- Source Version:
- 2024_01_01 - The source version
- Source Date:
- March 04, 2024 - RxNorm data last updated
- Source License Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source license contact information - Source Content Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source content contact information - Source Short Name:
- US Edition of SNOMED CT - The short name of a source as used by the NLM Knowledge Source Server
* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Patient Education
Ranitidine
Ranitidine is used to treat ulcers; gastroesophageal reflux disease (GERD), a condition in which backward flow of acid from the stomach causes heartburn and injury of the food pipe (esophagus); and conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome. Over-the-counter ranitidine is used to prevent and treat symptoms of heartburn associated with acid indigestion and sour stomach. Ranitidine is in a class of medications called H2 blockers. It decreases the amount of acid made in the stomach.
[Learn More]
* Please review the disclaimer below.